Selected Publications by Board Members of the LSINJ - Articles, Books, Chapters, Data Papers, Reviews and Conference Presentations

ASMI-04-0918.Online.pdf.pdf

Akin to the Great Revolutions or Ages, the Combinatorial Approach for Preempting Genetic Diseases Requires the Confluence of Independent Scientific and Societal Developments Emerging from Synergisms Between Serendipitous, Planned and Natural Progressions Significantly Magnifying the Impact Over the Simple Sum of their Individual Components or Subfields 

Ferez Soli Nallaseth1*, et al ,*Corresponding Author: Ferez Soli Nallaseth, Founding President, CEO, CSO and CFO for the LSINJ, USA. Postal Addresses: Life Sciences Institute of New Jersey, Email: FerezNallaseth@LifeSciencesInstituteNJ.com; fereznal25@lsinj.org 

https://actascientific.com/ASMI/pdf/ASMI-04-0918.pdf 


Shifting the therapeutic paradigm in medicine from post mutational (& pathological) intervention to preemption – a synopsis of the ‘nuts and bolts’ Ferez S. Nallaseth, MS, PhD, MOJ Proteomics Bioinform. 2019;8(2):4143.DOI: 10.15406/mojpb.2019.08.00264


What is the Life Sciences Institute of New Jersey? Why and how does it Exist? What are its goals? Ferez S. Nallaseth* Life Sciences Institute of New Jersey, Complex Biological Systems Alliance, 229 Parsons Court, Belle Mead, New Jersey 06502, USA 


Is There a Role for an Evolutionary Genetics Based Rational Health Policy In Global Biomedical, Health and Economic Policies? Nallaseth. J. Mol Biol OMICS . v3 :1.6.30.2014, (http://dx.doi.org/10.4172/2168-9547.1000e118) 


Is There A Role for an Evolutionary Genetics Based Rational Health Policy In Global Biomedical, Health and Economic Policies? Nallaseth. Mol Biol OMICS (http://dx.doi.org/10.4172/2168-9547.1000e118)

(https://www.hilarispublisher.com/open-access/what-is-the-life-sciences-institute-of-new-jersey-why-and-how-does-itexist-what-are-its-goals-2168-9547-1000130.pdf)

Google Scholar PDF Full Text

(2) LSINJ and it's global, scientific, professional and occupational diversity necessary for promoting it's core mission of preempting genetic disease lesions

Comm.Miss.Diver.LSINJ.BM.11.26.2021.docx